|
시장보고서
상품코드
1863995
생명과학용 인공지능 시장 : 제공 내용별, 분석 방법별, 용도별, 최종사용자별, 실현 기술별, 유통 채널별, 지역별Artificial Intelligence in Life Science Market, By Offering, By Analytics, By Applicatio, By End User, By Enabling Technology, By Distribution Channel, By Geography |
||||||
생명과학용 인공지능 시장은 2025년에 37억 3,000만 달러 규모로 추정되며, 2032년까지 180억 9,000만 달러에 달할 것으로 예측됩니다. 2025년부터 2032년까지 CAGR은 25.3%로 예측됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 시장 규모(2025년) | 37억 3,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간 CAGR(2025-2032년) | 25.30% | 예측 금액(2032년) | 180억 9,000만 달러 |
세계 생명과학 인공지능 시장은 최첨단 컴퓨팅 기술과 생물학적 연구의 혁신적인 융합을 통해 제약회사, 생명공학 기업 및 연구기관이 신약 개발, 임상시험 및 환자 치료 방법을 근본적으로 재구성하고 있습니다. 이 역동적인 시장은 기계 학습 알고리즘, 자연어 처리, 컴퓨터 비전, 예측 분석의 적용을 포함하며 유전체학, 단백질학, 신약 개발, 맞춤형 의료 등의 분야에서 과학적 혁신을 가속화할 것입니다.
AI 기술은 연구자들이 방대한 데이터세트를 분석하고, 새로운 약물 타겟을 식별하고, 임상시험 설계를 최적화하고, 치료 결과를 전례 없는 정확도와 속도로 예측할 수 있게함으로써 기존의 생명과학 연구 방식에 혁명을 불러일으키고 있습니다. 생명과학 분야에서의 AI 통합은 생물학적 데이터의 급격한 증가, 컴퓨팅 성능의 향상, 그리고 새로운 치료법을 시장에 출시하는 데 소요되는 시간과 비용을 줄여야 하는 시급한 필요성에 의해 추진되고 있습니다. 분자 화합물의 가상 스크리닝부터 AI 기반 진단 도구, 로봇을 이용한 실험실 자동화까지, 이러한 기술들은 과학적 발견과 의료 제공의 새로운 패러다임을 창출하고, 인공지능을 현대 생명과학 생태계에서 혁신의 필수적인 촉매제로 자리매김하고 있습니다.
시장 역학
세계 생명과학용 인공지능 시장은 산업 환경을 근본적으로 변화시키는 여러 주요 촉진요인에 의해 주도되고 있습니다. 유전체 시퀀스 데이터, 임상 기록, 바이오마커 정보를 포함한 생물학적 데이터 생성량이 기하급수적으로 증가함에 따라, 복잡한 데이터세트에서 의미 있는 지식을 처리하고 추출할 수 있는 고도화된 AI 알고리즘이 요구되고 있습니다. 기존 의약품 개발 프로세스에 따른 비용 증가와 장기화(26억 달러 이상, 10-15년 소요)로 인해 제약사들은 AI 솔루션을 도입하고 있습니다. 이를 통해 새로운 치료제를 시장에 출시하는 데 소요되는 시간과 재정적 부담을 크게 줄일 수 있기 때문입니다. 또한, 맞춤형 의료와 정밀치료에 대한 관심이 높아지면서 환자별 데이터를 분석하고 치료 프로토콜을 최적화하는 AI 기반 툴에 대한 수요가 증가하고 있습니다.
그러나 시장에는 눈에 띄는 제약도 존재합니다. 임상 도입 전 AI 알고리즘에 대한 광범위한 검증을 요구하는 엄격한 규제 프레임워크, 환자 정보 취급과 관련된 데이터 프라이버시 문제, AI 기술과 생명과학 응용 사이의 간극을 효과적으로 메울 수 있는 숙련된 전문가 부족 등이 그 예입니다.
또한, AI 인프라 도입을 위한 높은 초기 투자 비용과 기존 검사실 및 임상 워크플로우에 AI 시스템 통합의 어려움은 소규모 조직에 큰 장벽으로 작용하고 있습니다. 이러한 도전에도 불구하고, 시장에는 큰 기회가 존재합니다. 그 배경에는 AI를 활용한 생명과학 분야 스타트업에 대한 벤처 캐피털의 투자 증가, 기술 대기업과 제약사의 협력 확대, 의료 영상 및 병리 진단 등의 분야에서의 적용 확대, 모든 규모의 조직이 고도의 컴퓨팅 파워에 접근할 수 있는 클라우드 AI 플랫폼의 채택 가속화 등이 있습니다. 클라우드 기반 AI 플랫폼의 채택 가속화 등을 꼽을 수 있습니다.
본 보고서의 주요 특징
- 세계의 생명과학용 인공지능(AI) 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
- 또한, 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
- 세계 생명과학 인공지능 시장의 주요 기업 프로파일을 회사 개요, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등 주요 매개 변수를 기준으로 정리하여 수록하였습니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- '세계 생명과학용 인공지능 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 생명과학 인공지능 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
- 분석 목적
- 가정
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학·규제·동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 발매/승인
- PEST 분석
- Porter's Five Forces 분석
- 기업 인수합병(M&A) 시나리오
- 업계 동향
제4장 세계의 생명과학용 인공지능 시장 : 제공 내용별(2020-2032년)
- 소개
- 소프트웨어(알고리즘, AI 탑재 플랫폼, 모듈 등)
- 하드웨어(컴퓨팅 인프라, 특수 센서, 영상 기기 등)
- 서비스(컨설팅, 통합, 트레이닝, 정비 등)
제5장 세계의 생명과학용 인공지능 시장 : 전개 방식별(2020-2032년)
- 소개
- 클라우드 기반
- 온프레미스
제6장 세계의 생명과학용 인공지능 시장 : 분석 방법별(2020-2032년)
- 소개
- 기술적/보고
- 예측적
- 처방적/의사결정 서포트
- 생성/합성 데이터/AI 기반 분자 생성
제7장 세계의 생명과학용 인공지능 시장 : 용도별(2020-2032년)
- 소개
- Drug Discovery & Development
- 임상시험 설계·최적화
- 의료 진단, 영상 진단/바이오마커 검출
- 정밀의료, 맞춤형 의료
- 바이오테크놀러지/바이오프로세싱/오믹스
- 환자 모니터링, RWE(Real-World Evidence)
- 규제/안전성 및 약물감시
제8장 세계의 생명과학용 인공지능 시장 : 최종사용자별(2020-2032년)
- 소개
- 제약·바이오테크놀러지 기업
- CRO(의약품 임상시험수탁기관)/임상 개발 회사
- 의료기기 제조업체
- 학술연구기관
- 의료기관(병원/진료소)
- 규제기관과 안전 위원회
제9장 세계의 생명과학용 인공지능 시장 : 실현 기술별(2020-2032년)
- 소개
- 머신러닝/통계 모델
- 자연어 처리(NLP)/텍스트 마이닝
- 의료기기 제조업체
- 컴퓨터 비전/이미징 AI
- 딥러닝/신경망
- 하이브리드·멀티모달 AI(모달리티 융합)
제10장 세계의 생명과학용 인공지능 시장 : 유통 채널별(2020-2032년)
- 소개
- 병원 약국
- 소매 약국
- 온라인 약국
제11장 세계의 생명과학용 인공지능 시장 : 지역별(2020-2032년)
- 소개
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카공화국
- 북아프리카
- 중앙아프리카
제12장 경쟁 구도
- Insilico Medicine
- Atomwise
- Exscientia
- Schrodinger
- Recursion Pharmaceuticals
- BenevolentAI
- Cyclica
- Iktos
- Owkin
- Evogene
- Anima Biotech
- Generate Biomedicines
- Nimbus Therapeutics
- DeepMind/Isomorphic Labs
- IBM Watson Health
제13장 애널리스트의 제안
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map(COM)
제14장 참고문헌과 분석 방법
- 참고문헌
- 분석 방법
- Coherent Market Insights 소개
Artificial Intelligence in Life Science Market is estimated to be valued at USD 3.73 Bn in 2025 and is expected to reach USD 18.09 Bn by 2032, growing at a compound annual growth rate (CAGR) of 25.3% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3.73 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 25.30% | 2032 Value Projection: | USD 18.09 Bn |
The global artificial intelligence in life science market represents a transformative convergence of cutting-edge computational technologies and biological research, fundamentally reshaping how pharmaceutical companies, biotechnology firms, and research institutions approach drug discovery, clinical trials, and patient care. This dynamic market encompasses the application of machine learning algorithms, natural language processing, computer vision, and predictive analytics to accelerate scientific breakthroughs in areas such as genomics, proteomics, drug development, and personalized medicine.
AI technologies are revolutionizing traditional life science methodologies by enabling researchers to analyze vast datasets, identify novel drug targets, optimize clinical trial designs, and predict treatment outcomes with unprecedented accuracy and speed. The integration of AI in life sciences is driven by the exponential growth of biological data, increasing computational power, and the urgent need to reduce the time and cost associated with bringing new therapies to market. From virtual screening of molecular compounds to AI-powered diagnostic tools and robotic laboratory automation, these technologies are creating new paradigms for scientific discovery and healthcare delivery, positioning artificial intelligence as an indispensable catalyst for innovation in the modern life sciences ecosystem.
Market Dynamics
The global artificial intelligence in life science market is propelled by several key drivers that are fundamentally transforming the industry landscape. The exponential increase in biological data generation, including genomic sequencing data, clinical records, and biomarker information, necessitates sophisticated AI algorithms capable of processing and extracting meaningful insights from complex datasets. The rising costs and extended timelines associated with traditional drug development processes, which can exceed USD 2.6 billion and span 10-15 years, are driving pharmaceutical companies to adopt AI solutions that can significantly reduce both financial burden and time-to-market for new therapeutics. Additionally, the growing emphasis on personalized medicine and precision therapeutics is creating substantial demand for AI-powered tools that can analyze patient-specific data to optimize treatment protocols.
However, the market faces notable restraints including stringent regulatory frameworks that require extensive validation of AI algorithms before clinical implementation, data privacy concerns related to patient information handling, and the shortage of skilled professionals who can effectively bridge the gap between AI technology and life science applications.
Furthermore, the high initial investment costs for implementing AI infrastructure and the challenge of integrating AI systems with existing laboratory and clinical workflows present significant barriers for smaller organizations. Despite these challenges, the market presents tremendous opportunities driven by increasing venture capital investments in AI-driven life science startups, growing collaborations between technology giants and pharmaceutical companies, expanding applications in areas such as medical imaging and diagnostic pathology, and the accelerating adoption of cloud-based AI platforms that democratize access to advanced computational capabilities across organizations of all sizes.
Key Features of the Study
- This report provides in-depth analysis of the global artificial intelligence in life science market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global artificial intelligence in life science market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Insilico Medicine, Atomwise, Exscientia, Schrodinger, Recursion Pharmaceuticals, BenevolentAI, Cyclica, Iktos, Owkin, Evogene, Anima Biotech, Generate Biomedicines, Nimbus Therapeutics, DeepMind/Isomorphic Labs, and IBM Watson Health
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global artificial intelligence in life science market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence in life science market
Market Segmentation
- Offering Insights (Revenue, USD Bn, 2020 - 2032)
- Software (algorithms, AI-powered platforms, modules, etc.)
- Hardware (compute infrastructure, specialized sensors, imaging devices, etc.)
- Services (consulting, integration, training, maintenance, etc.)
- Deployment Model Insights (Revenue, USD Bn, 2020 - 2032)
- Cloud Based
- On-premise
- Analytics Insights (Revenue, USD Bn, 2020 - 2032)
- Descriptive/Reporting
- Predictive
- Prescriptive/Decision support
- Generative/Synthetic data/AI-driven molecule generation
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Drug Discovery and Development
- Clinical Trials Design and Optimization
- Medical Diagnosis and Imaging/Biomarker Detection
- Precision and Personalized Medicine
- Biotechnology/Bioprocessing/Omics
- Patient Monitoring and Real-World Evidence (RWE)
- Regulatory/Safety and Pharmacovigilance
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)/Clinical Research Firms
- Medical Device Manufacturers
- Academic and Research Institutions
- Healthcare Providers (Hospitals/Diagnostic Clinics)
- Regulatory Agencies and Safety Boards
- Enabling Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Machine Learning/Statistical Models
- Natural Language Processing (NLP)/Text Mining
- Computer Vision/Imaging AI
- Deep Learning/Neural Networks
- Hybrid and Multi-modal AI(fusion of modalities)
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Insilico Medicine
- Atomwise
- Exscientia
- Schrodinger
- Recursion Pharmaceuticals
- BenevolentAI
- Cyclica
- Iktos
- Owkin
- Evogene
- Anima Biotech
- Generate Biomedicines
- Nimbus Therapeutics
- DeepMind/Isomorphic Labs
- IBM Watson Health
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Artificial Intelligence in Life Science Market, By Offering
- Global Artificial Intelligence in Life Science Market, By Deployment Model
- Global Artificial Intelligence in Life Science Market, By Analytics
- Global Artificial Intelligence in Life Science Market, By Application
- Global Artificial Intelligence in Life Science Market, By End User
- Global Artificial Intelligence in Life Science Market, By Enabling Technology
- Global Artificial Intelligence in Life Science Market, By Distribution Channel
- Global Artificial Intelligence in Life Science Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Artificial Intelligence in Life Science Market, By Offering, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Software (algorithms, AI-powered platforms, modules, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hardware (compute infrastructure, specialized sensors, imaging devices, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Services (consulting, integration, training, maintenance, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Artificial Intelligence in Life Science Market, By Deployment Model, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cloud Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- On-premise
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Artificial Intelligence in Life Science Market, By Analytics, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Descriptive/Reporting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Predictive
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Prescriptive/Decision support
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Generative/Synthetic data/AI-driven molecule generation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Artificial Intelligence in Life Science Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Clinical Trials Design and Optimization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Medical Diagnosis and Imaging/Biomarker Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Precision and Personalized Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biotechnology/Bioprocessing/Omics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Patient Monitoring and Real-World Evidence (RWE)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Regulatory/Safety and Pharmacovigilance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Artificial Intelligence in Life Science Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract Research Organizations (CROs)/Clinical Research Firms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Medical Device Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Healthcare Providers (Hospitals/Diagnostic Clinics)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Regulatory Agencies and Safety Boards
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Artificial Intelligence in Life Science Market, By Enabling Technology, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Machine Learning/Statistical Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Natural Language Processing (NLP)/Text Mining
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Medical Device Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Computer Vision/Imaging AI
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Deep Learning/Neural Networks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hybrid and Multi-modal AI(fusion of modalities)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Artificial Intelligence in Life Science Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
11. Global Artificial Intelligence in Life Science Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive landscape
- Insilico Medicine
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Atomwise
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Exscientia
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Schrodinger
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Recursion Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BenevolentAI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cyclica
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Iktos
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Owkin
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Evogene
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Anima Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Generate Biomedicines
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nimbus Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- DeepMind/Isomorphic Labs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IBM Watson Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About Us
